Patienterne bør underrettes om denne potentielle risiko og behovet for at blive observeret i 3 timer i et sundhedscenter, hver gang ZYPADHERA bliver administreret.
Patients should be advised about this potential risk and the need to be observed for 3 hours in a healthcare facility each time ZYPADHERA is administered.